BioSpace News Archive

The company has developed the first and only non-invasive way to collect stem cells, which have been used to treat ailments ranging from torn ligaments to arthritis to kidney disease

This immunological response is accompanied by decreased tumor load in approximately 81% of those same patients, equivalent to 65% of the total number of treated patients.

As per the Company’s press release dated September 27, 2019, Health Canada requested minor updates.

MC10, Inc., the developer of BioStamp nPoint, an end-to-end system for physiological data collection and analytics, announced today a collaboration with the University of Vermont, a leading academic research institution.

The national STEMx network announced funding for five states to expand quality STEM education programs and add to the national conversation on innovative education.

Included in the Facility is an uncommitted option to increase the Facility by an incremental $25 million to a total of $31 million, subject to agreement by BMO and satisfaction of certain legal and business conditions.

A conference call hosted by Chairman and CEO, Calvin H. Knowlton, Ph.D., President and Chief Marketing and Business Development Officer, Orsula V. Knowlton, PharmD, MBA, and Chief Financial Officer, Brian W. Adams will follow at 5:00 p.m. ET.

Partners In Care announced today that the Partners In Care Accountable Care Organization generated $546 Per Member Per Year in savings for Performance Year 2018 for the Centers for Medicare and Medicaid’s Medicare Shared Savings Program By delivering 50% more savings than the minimum threshold required by CMS, and significantly lowering the cost of care, the ACO member providers earned millions in shared savings.

PCCA has named Jasper Lovoi III, PharmD, RPh, of The Woodlands Compounding Pharmacy in Shenandoah, Texas, as its M. George Webber, PhD, 2019 Compounding Pharmacist of the Year and has awarded Courtney Junop, BSP, of The Medicine Shoppe Pharmacy & Compounding Centre in Saskatoon, Saskatchewan, its 2019 George Roentsch, RPh, Scholarship. Both awards were presented on October 10, during the company’s International Seminar 2019 in Houston, Texas.

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that the company will participate in the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2019 in Boston, October 27-30, including a poster presentation on October 27th.